阿托伐他汀对终末期肾脏病患者脑钠肽及心功能的影响(2)
 |
| 第1页 |
参见附件。
[2] Vesely DL. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure，renal failure and cancer[J]. Clin Exp Pharmacol Physiol，2006，33(3)：169-176.
[3] Uzuki M，Yamamoto K，W atanabe S，et al. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension[J]. Med，2000，108(3)：627-633.
[4] DeFilippi C，Van Kimmenade RR，Pinto YM. Amino terminal pro-B-type natriuretic testing in renal disease[J]. Am J Cardiol，2008，4；82-88.
[5] Maisel AS，Krishnaswamy P，Nowak RM，et al. Rapid measurement of Btype natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med，2002；347(3)：161-167.
[6] Tousoulis D，Antoniades，Cbosinakou E，et al. Effects of Atorvastatin on reactive inflammatory process in patients with congestive heart failure[J]. Atherosclerosis，2005，23(178)：359-363.
[7] Richard Kones. The Jupiter study CRP screening and aggressive statin therapy implications for the primary prevention of cardiovascular diseas[J]. Ther Adv Cardiovasc Dis，2009，3(4)：309-315.
[8] Nakay R，Uzui H，Shimizu H，et al. Pravastatin suppresses the increase in matalloproteinase-2 levels after acute myocarction [J]. Int J Cardiol，2005，105(1)：67-73.
(收稿日期：2012-12-26 本文编辑：魏玉坡)
您现在查看是摘要介绍页，详见PDF附件(1980kb)。